ScholarIQanswers from OpenAlex & ORCID
Mary L. Gemignani
ResearcherPublications, citations & collaboration network
Mary L. Gemignani is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Mary L. Gemignani have?
ScholarIQindexed works
Mary L. Gemignani has 205 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mary L. Gemignani have?
ScholarIQcitation count
Mary L. Gemignani has 6,642 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Mary L. Gemignani?
ScholarIQh-index
Mary L. Gemignani has an h-index of 45 in OpenAlex.
What is the i10-index of Mary L. Gemignani?
ScholarIQi10-index
Mary L. Gemignani has an i10-index of 89 in OpenAlex.
What is the ORCID of Mary L. Gemignani?
ScholarIQorcid
The ORCID for Mary L. Gemignani is on the source record.
What is the OpenAlex record for Mary L. Gemignani?
ScholarIQopenalex
The OpenAlex for Mary L. Gemignani is on the source record.
What are the most-cited papers on Mary L. Gemignani?
ScholarIQmost cited works
The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node Dissection
Arpana Naik, Jane V. Fey, Mary L. Gemignani, Alexandra S. Heerdt, Leslie L. Montgomery, Jeanne A. Petrek, Elisa Port, Virgilio Sacchini, Lisa M. Sclafani, Kimberly VanZee, Raquel Wagman, Patrick I. Borgen, Hiram S. Cody
How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study
Anita Mamtani, Andrea V. Barrio, Tari A. King, Kimberly J. Van Zee, George Plitas, Melissa Pilewskie, Mahmoud El‐Tamer, Mary L. Gemignani, Alexandra S. Heerdt, Lisa M. Sclafani, Virgilio Sacchini, Hiram S. Cody, Sujata Patil, Monica Morrow
Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?
Nadeem R. Abu‐Rustum, Fady Khoury‐Collado, Neeta Pandit‐Taskar, Robert A. Soslow, Fanny Dao, Yukio Sonoda, Douglas A. Levine, Carol L. Brown, S. Dennis, Richard R. Barakat, Mary L. Gemignani
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma
Mary L. Gemignani, Alan C. Schlaerth, Faina Bogomolniy, Richard R. Barakat, Oscar Lin, Robert A. Soslow, Ennapandam Venkatraman, Jeff Boyd
Isosulfan Blue Dye Reactions During Sentinel Lymph Node Mapping for Breast Cancer
Leslie L. Montgomery, Alisa C. Thorne, Kimberly J. Van Zee, Jane V. Fey, Alexandra S. Heerdt, Mary L. Gemignani, Elisa Port, Jeanne A. Petrek, Hiram S. Cody, Patrick I. Borgen